Efficacy and safety of tacrolimus compared with ciclosporin A in renal transplantation: three-year observational results

Abstract

Patients treated with tacrolimus had significantly higher combined endpoint-free survival rates and lower acute rejection rates with less immunosuppressive medication at 36 months.